Skip to search formSkip to main contentSkip to account menu

Dilevalol

Known as: Labetalol, (R,R)-Isomer, R,R Labetalol, R,R-Labetalol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
1. This study investigated the influence of age on the pharmacokinetics, pharmacodynamics, general tolerability and concentration… 
1988
1988
The bioavailability and pharmacokinetics of dilevalol following oral and intravenous administration were investigated in 12… 
1988
1988
Dilevalol combines a nonselective blocking action on beta-receptors with selective beta 2-agonist activity. In this double-blind… 
1988
1988
It is not surprising that there has been a search for compounds that combine two useful antihypertensive properties. The… 
1988
1988
The effects of dilevalol, a new β‐adrenergic blocking agent with β‐agonism, on renal function were determined in two groups of… 
1988
1988
The pharmacokinetics of unchanged and total (unchanged plus Glusulase [Biotechnology Systems, Boston, MA]) released dilevalol and… 
1988
1988
Dilevalol hydrochloride, the R-R optical isomer of labetalol hydrochloride, was administered intravenously to subjects with…